Long-term results and predictors of survival after surgical resection of patients with lung cancer and interstitial lung diseases  Toshihiko Sato, MD, PhD, Atsushi Watanabe, MD, PhD, Haruhiko Kondo, MD, PhD, Masato Kanzaki, MD, PhD, Kenichi Okubo, MD, PhD, Kohei Yokoi, MD, PhD, Kazuya Matsumoto, MD, PhD, Takashi Marutsuka, MD, PhD, Hirohiko Shinohara, MD, PhD, Satoshi Teramukai, PhD, Kazuma Kishi, MD, PhD, Masahito Ebina, MD, PhD, Yukihiko Sugiyama, MD, PhD, Okumora Meinoshin, MD, PhD, Hiroshi Date, MD, PhD  The Journal of Thoracic and Cardiovascular Surgery  Volume 149, Issue 1, Pages 64-70.e2 (January 2015) DOI: 10.1016/j.jtcvs.2014.08.086 Copyright © 2015 The American Association for Thoracic Surgery Terms and Conditions

Figure 1 A, Overall survival of patients with ILDs who underwent pulmonary resection. B, Survival of the wedge resection, segmentectomy, and lobectomy groups in patients with stage IA; 5-year survival of each group was 29.2%, 60.0%, and 68.6%, respectively. No significant difference was found between the wedge resection and segmentectomy groups (log-rank P = .365). C, For all stages, 5-year survival of patients with lower %VC (≤80%) and normal %VC (>80%) was 43.8% and 20.8%, respectively (log-rank test, P < .0001). D, For patients with stage IA, 5-year survival of patients with lower %VC (≤80%) and normal %VC (>80%) was 64.3% and 20.0%, respectively (log-rank test, P < .0001). %VC, Percent vital capacity. The Journal of Thoracic and Cardiovascular Surgery 2015 149, 64-70.e2DOI: (10.1016/j.jtcvs.2014.08.086) Copyright © 2015 The American Association for Thoracic Surgery Terms and Conditions